TransThera Sciences (Nanjing), Inc. 02617.HK 價格預測與預測

Q: 技術分析指標如何適用於 02617.HK？

根據技術分析，TransThera Sciences (Nanjing), Inc. 的綜合信號為 Sell。TransThera Sciences (Nanjing), Inc. 有 2 個買入信號，0 個中性信號和 5 個賣出信號。

Q: 02617.HK 的費波那契回檔水準是多少？

TransThera Sciences (Nanjing), Inc. 的費波那契回檔水準是 高於 0% 水準。

Q: TransThera Sciences (Nanjing), Inc. 的 RSI 是多少？

TransThera Sciences (Nanjing), Inc. 的 RSI 目前為 10.26，表明處於 超賣 狀態

Q: TransThera Sciences (Nanjing), Inc. 接下來 12 個月的價格是多少？

TransThera Sciences (Nanjing), Inc. 02617.HK 接下來 12 個月的價格預估為 $0。

Q: TransThera Sciences (Nanjing), Inc. 預計會漲到多高？

據華爾街分析師稱，TransThera Sciences (Nanjing), Inc. 預計將達到 $0 的高預測值。

首頁

股票

02617.HK

預測

TRANSTHERA-B (02617.HK)

TransThera Sciences (Nanjing), Inc.

HK$79.85

-4.48%

$-3.75

休市： Jan 21, 16:00:00 HKT

關鍵數據

前收市價

$83.3

開盤價

$83.6

當日範圍

$78.25 - $84.25

52週區間

$20.2 - $679.5

交易量

1.0M

平均成交量

1.7M

每股盈餘 (TTM)

-0.67

股息收益率

市值

$24.0B

什麼是 TRANSTHERA-B？

TransThera Sciences (Nanjing), Inc. engages in the research and development of clinical biopharmaceutics. The company is headquartered in Nanjing, Jiangsu and currently employs 121 full-time employees. The company went IPO on 2025-06-23. The firm's core product Tinengotinib is a registrational clinical stage, internally discovered and developed, MTK inhibitor indicated for certain relapsed or refractory, drug-resistant solid tumors. The firm's oncology pipeline includes TT-00973 (against AXL), TT-01488 (for hematologic malignancies), TT-01688 (for inflammatory diseases) and TT-00920 (for chronic heart failure). The products are capable of being efficacious in a broad range of cancer types (including prostate cancer, HCC, breast cancer, and BTC). The company is also applied to cure hepatocellular carcinoma, breast cancer, biliary tract cancer and Pan-FGFR solid tumor.

功能特性

交易策略

資源

市場

02617.HK 股價預測摘要

02617.HK stock price ended at $82.3 on 星期三, after dropping 1.20%

On the latest trading day Jan 21, 2026, the stock price of 02617.HK fell by 1.20%, dropping from $93.00 to $82.30. During the session, the stock saw a volatility of 15.96%, with prices oscillating between a daily low of $80.20 and a high of $93.00. On the latest trading day, the trading volume for 02617.HK decreased by 1.7M shares, aligning with the declining prices, which may indicate weakening market confidence in the near term. In total, 175.0K shares were traded, with a market value of approximately $24.8B.

02617.HK 技術面訊號

技術面訊號摘要

購買訊號 2

中性訊號 0

賣出訊號 5

Strong Sell

Sell

Neutral

Buy

Strong Buy

02617.HK 目前顯示 2 個買入訊號與 5 個賣出訊號。該股票自 12:00 AM 以來一直處於下跌趨勢狀態，在此期間價格總共變動了 -13.82%。整體而言，技術指標顯示中期後市趨勢為 Sell。

02617.HK 的看漲／看跌訊號

我們的演算法透過分析移動平均線、RSI、MACD 和成交量等關鍵指標，為02617.HK生成看漲和看跌訊號。這些見解可助您做出明智的投資決策。

後續問題

技術分析指標如何適用於 02617.HK？



02617.HK 的費波那契回檔水準是多少？



TransThera Sciences (Nanjing), Inc. 的 RSI 是多少？



TransThera Sciences (Nanjing), Inc. 接下來 12 個月的價格是多少？



TransThera Sciences (Nanjing), Inc. 預計會漲到多高？



TransThera Sciences (Nanjing), Inc.（02617.HK）價格

02617.HK 股價走勢圖